ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Update on the DARE-19 Phase III Trial for Farxiga in COVID-19 americanpharmaceuticalreview
April 13, 2021AstraZeneca and Saint Luke’s Mid America Heart Institute announced high-level results of the primary analysis from the DARE-19 Phase III trial assessing the potential of Farxiga (dapagliflozin) to treat patients hospitalized with COVID-19 who are at ...
Pharma Sources Insight July 2025
